'It's a start in showing us we have the ability to make treatments against this coronavirus,' Fmr. FDA Commissioner Hamburg says of positive results in clinical trials for the drug Remdesivir. 'We need to know more about this drug and about this virus.'
After Gilead Sciences shows positive results for a study on an experimental coronavirus drug treatment, former FDA Commissioner Dr. Peggy Hamburg tells Andrea Mitchell that "it's a start in showing us we have the ability to make treatments against this coronavirus.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
U.S. FDA moving with 'lightning speed' on Gilead's COVID-19 drug: BloombergThe U.S. Food and Drug Administration is working at 'lightning speed' to review data on Gilead Sciences Inc's experimental antiviral drug remdesivir in treating COVID-19 disease, the head of the agency told Bloomberg in an interview.
続きを読む »
FDA moving at 'lightning speed' on remdesivir drug as coronavirus treatmentFDA Commissioner Stephen Hahn says the agency is moving at 'lightning speed' on remdesivir but must look at 'the totality of data' before issuing emergency use authorization of the drug.
続きを読む »
Remdesivir maker 'moving very quickly' with FDA on possible coronavirus use, CEO saysThe company thinks it could make millions of treatment courses of remdesivir available by the end of the year if it receives FDA approval, the Gilead CEO said.
続きを読む »
A ventilator developed by NASA has been approved by the FDA for coronavirus patientsA high-pressure ventilator prototype developed by NASA engineers to help coronavirus patients was approved by the Food and Drug Administration on Thursday, according to NASA.
続きを読む »
FDA allows emergency use of drug for coronavirus
続きを読む »